Pages that link to "Q53300461"

The following pages link to High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. (Q53300461):

Displaying 21 items.

• Epigenetic silencing of protocadherin 10 in colorectal cancer (Q33597607) (← links)
• Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. (Q33838679) (← links)
• Non-clustered protocadherin (Q34891159) (← links)
• PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance (Q36567898) (← links)
• Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer (Q37001109) (← links)
• PCDH10 Interacts With hTERT and Negatively Regulates Telomerase Activity (Q37328310) (← links)
• Beyond E-cadherin: roles of other cadherin superfamily members in cancer (Q38179961) (← links)
• Regulation of Wnt signaling by protocadherins (Q38642725) (← links)
• PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis (Q38732488) (← links)
• Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma (Q38903947) (← links)
• Aberrant expression and functions of protocadherins in human malignant tumors (Q38905879) (← links)
• PCDH10 is a candidate tumour suppressor gene in medulloblastoma. (Q39539408) (← links)
• Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma (Q42643718) (← links)
• Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer (Q44129766) (← links)
• Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer (Q44691945) (← links)
• Expression of delta-protocadherins in the spinal cord of the chicken embryo (Q51843015) (← links)
• Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. (Q53544125) (← links)
• Modulation of mutant KrasG12D-driven lung tumorigenesis in vivo by gain or loss of PCDH7 function (Q58585653) (← links)
• High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma (Q64055267) (← links)
• Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma (Q64228155) (← links)
• Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression (Q84032542) (← links)